Get 20% lifetime commission for referring investors to digrin.com
here.
Agenus Inc. ( AGEN) - Key Metrics
AGEN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.84 | -$0.01 | -$0.75 | -$0.75 |
| 2026Q1 | $0.89 | $1.03 | -$0.95 | -$0.95 |
| 2025Q4 | $0.97 | -$0.30 | -$0.47 | -$0.47 |
| 2025Q3 | $0.95 | $2 | -$0.46 | -$0.46 |
| 2025Q2 | $0.91 | -$0.99 | -$0.72 | -$0.72 |
AGEN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -52.40 |
| 2026Q1 | 0% | 0.81 |
| 2025Q4 | 0% | -2.62 |
| 2025Q3 | 0% | 0.48 |
| 2025Q2 | 0% | -1.14 |
AGEN
Price: $7.13
52 week price:
Payout Ratio Range:
Earnings Per Share: 2.99 USD
P/E Ratio: 2.45
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 207310
Ebitda: -30.2 millionMarket Capitalization: 329.5 million